Dariohealth publishes clinical outcomes demonstrating the impact of using a single digital therapeutics platform for multiple conditions

New york, feb. 9, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced the publication of a retrospective, real-world study demonstrating the impact of managing blood pressure and diabetes together on the same digital platform in the leading peer-reviewed journal for digital medicine and health, the journal of medical internet research.     to better understand the impact of an integrated, multi-condition digital therapeutics platform, the study compared the results of two propensity-matched groups of people using dario's digital therapeutic platform to monitor and manage blood sugar levels.
DRIO Ratings Summary
DRIO Quant Ranking